Illumina faces challenges from China's entity list and potential upside from Trump-era tariffs.
2 reports, 2 independent
Updated Fri 00:00
No new developments lately
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Illumina faces challenges from China's entity list and potential upside from Trump-era tariffs.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Tariffs and trade controls between US and China.Also in this story
- Beijing is discussing a framework deal aimed at implementing mutual tariff cuts.
- US actions prompt Chinese trade countermeasures, with the CCP focusing on trade surplus and dollar earnings.
- China has sought a WTO challenge against US tariffs, which are being used to gain an upper hand in global markets.
- Trade tensions between the U.S. and China regarding the polysilicon supply chain.
The entities involved
-
Illumina
American company that develops systems for the analysis of genetic variation
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)